1. Home
  2. AMCX vs STTK Comparison

AMCX vs STTK Comparison

Compare AMCX & STTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Networks Inc.

AMCX

AMC Networks Inc.

HOLD

Current Price

$7.59

Market Cap

331.2M

ML Signal

HOLD

Logo Shattuck Labs Inc.

STTK

Shattuck Labs Inc.

HOLD

Current Price

$4.04

Market Cap

275.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMCX
STTK
Founded
1980
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
331.2M
275.9M
IPO Year
2011
2020

Fundamental Metrics

Financial Performance
Metric
AMCX
STTK
Price
$7.59
$4.04
Analyst Decision
Sell
Buy
Analyst Count
5
7
Target Price
$7.00
$6.20
AVG Volume (30 Days)
503.9K
375.1K
Earning Date
05-13-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
132.55
27.32
EPS
1.66
N/A
Revenue
$2,311,801,000.00
$5,721,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.53
N/A
Revenue Growth
N/A
245.26
52 Week Low
$5.41
$0.69
52 Week High
$10.28
$4.89

Technical Indicators

Market Signals
Indicator
AMCX
STTK
Relative Strength Index (RSI) 44.30 50.83
Support Level $6.96 $3.52
Resistance Level $8.23 $4.23
Average True Range (ATR) 0.50 0.30
MACD 0.01 0.00
Stochastic Oscillator 28.25 56.90

Price Performance

Historical Comparison
AMCX
STTK

About AMCX AMC Networks Inc.

AMC Networks owns several linear pay-TV networks, including AMC, WE tv, BBC America, IFC, and SundanceTV. AMC, its most widely distributed network, reached 60 million pay-TV households in the US at the end of 2024. The firm also had nearly 12.5 million US streaming subscribers, with AMC+ as the flagship streaming platform. With both its linear networks and streaming offerings, the firm caters to specific niche audiences. Over the last 15 years, AMC has shifted its focus to original scripted programming from classic movies. It creates content through AMC Studios and also generates revenue from licensing content. Following an international divestiture at the end of 2023, domestic operations make up nearly 90% of total revenue.

About STTK Shattuck Labs Inc.

Shattuck Labs Inc is a biotechnology company specializing in the development of potential treatments for inflammatory and immune-mediated diseases. It is developing a potentially first-in-class antibody for the treatment of inflammatory bowel disease (IBD) and other inflammatory and immune-mediated diseases. The company's expertise in protein engineering and the development of novel tumor necrosis factor (TNF) receptor therapeutics comes together in its main program, SL-325, which has the potential to be a first-in-class death receptor 3 (DR3) antagonist antibody. In addition, the company is developing SL-425, a half-life extended version of SL-325, and multiple other preclinical DR3-based bispecific antibodies, for the treatment of patients with IBD.

Share on Social Networks: